Results 231 to 240 of about 44,321 (338)

Estimation of benefit to bispecific antibodies in US patients with lymphoma and multiple myeloma. [PDF]

Blood Adv
Rios-Olais FA, Hilal T.
europepmc   +1 more source

1208 Comparison of receptor occupancy and optimal doses of PD1xCD40 and PDL1xCD40 bispecific antibodies using physiologically based pharmacokinetic modeling [PDF]

Alexandra Diakonova, Dmitry Shchelokov, Oleg Demin, Oleg Demin   +3 more
openalex   +1 more source

Tumor‐Derived Interleukin 35 Promotes Fibrosis in the Tumor Microenvironment of Pancreatic Cancer by Activating Pancreatic Stellate Cells

Advanced Science, Volume 13, Issue 5, 27 January 2026.
This study demonstrates that tumor‐derived IL‐35 promotes pancreatic cancer fibrosis by indirectly activating pancreatic stellate cells through IGFBP2/IGF‐1R/PI3K‐Akt and Tsp‐1/TGF‐β pathways. IL‐35 blockade reduces stromal fibrosis, restores chemosensitivity, and synergizes with gemcitabine‐based regimens, highlighting IL‐35 as a promising therapeutic
Hui Li, Huizhi Sun, Jing Liu, Yan Wu, Lin Wei, Jianming Li, Yudong Yuan, Peng Xie, Chao Xu, Guolu Luo, Yuqi Guan, Yukuan Feng, Antao Chang, Jihui Hao, Chongbiao Huang   +14 more
wiley   +1 more source

Bispecific Antibodies in Solid Tumors: Advances and Challenges. [PDF]

Int J Mol Sci
Shan KS, Musleh Ud Din S, Dalal S, Gonzalez T, Dalal M, Ferraro P, Hussein A, Vulfovich M.   +7 more
europepmc   +1 more source

Real-world safety and mortality outcomes of CAR-T cell therapies versus bispecific antibodies in DLBCL: Insights from the faers database [PDF]

Fatma Temiz, Işık Atagündüz, Tayfur Toptaş   +2 more
openalex   +1 more source

BRIGHT Enables High‐SNR Live‐Cell Imaging of Non‐Repetitive Sequences via Bivalent Fluorescent Nanobody‐Mediated Cascade‐Dependent Illumination

Advanced Science, Volume 13, Issue 2, 9 January 2026.
BRIGHT is a newly developed live‐cell imaging system that integrates cascade amplification with background denoising through the bivalent binding capability and antigen‐dependent stability of a bivalent fluorescent nanobody targeting ALFA peptides.
Lei Feng, Tao Huang, Yanxi Han, Meng Tian, Duo Wang, Zilong Mei, Yu Ma, Yingshuo Ma, Jinming Li, Rui Zhang   +9 more
wiley   +1 more source

Exploring T-cell bispecific antibodies in gynecologic malignancy. [PDF]

Gynecol Oncol Rep
O'Brien E, Mayer CM, Arend RC.
europepmc   +1 more source

New antibody approaches to lymphoma therapy [PDF]

, 2014

core   +1 more source

Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast Nephropathy

American Journal of Hematology, Volume 101, Issue 1, Page 56-69, January 2026.
Disease‐specific, patient‐specific, and treatment‐related factors correlate with renal recovery. ABSTRACT Acute renal failure due to cast nephropathy (CAN) is a severe complication of multiple myeloma (MM). Here, we aimed to identify parameters associated with renal outcomes and survival in newly diagnosed MM patients with CAN‐related acute renal ...
Heinz Ludwig, Meletios Athanasios Dimopoulos, Evangelos Terpos, Sarah Bernhard, Foteini Theodorakakou, Meral Beksac, Guldane Cengiz‐Seval, Nelson Leung, Luca Arcaini, Silvia Mangiacavalli, Frank Bridoux, Hermine Agis, Aristeidis Chaidos, Francesca Gay, Dario Roccatello, Wolfgang Hilbe, Andrea Havasi, Daniele Derudas, Nattawat Klomjit, Kenar D. Jhaveri, Javier De La Rubia Comos, Efstathios Kastritis   +21 more
wiley   +1 more source

Bispecific antibodies: unleashing a new era in oncology treatment. [PDF]

Mol Cancer
Shui L, Wu D, Yang K, Sun C, Li Q, Yin R.   +5 more
europepmc   +1 more source